Literature DB >> 1006209

Liver involvement in polymyalgia rheumatica.

J von Knorring, C Wassatjerna.   

Abstract

The incidence of abnormal results in liver function tests was determined in 37 of 51 patients with polymyalgia rheumatica (PMR) or temporal arteritis. Fine-needle biopsies fo the liver were performed on 6 of these patients and the bile canalicular network and liver cytology were studied in the aspirate by enzyme-cytochemical methods. Of the 37 patients in whom it was measured, 23 (62%) had elevated concentrations of serum alkaline phosphatases (AP), mainly of hepatic origin. The concentrations of other serum enzymes associated with hepatic function were normal in all 37 patients. BSP retention was studied in 13 patients and was abnormal in 6 (46%). Three of the 4 patients for whom smears were stained for AP activity had an increase in this activity in their bile canaliculi that corresponded to a rise in the serum concentration of AP. In one of these 3 patients, smears stained for naphthylamidase showed that bile canaliculi had a calibre wider than normal and had granular walls. A second biopsy performed 10 days showed a partial reversal of these changes. Mild fatty infiltration of the liver cells was seen in 2 patients; one patient whose serum concentration of AP was normal also had normal liver cells and bile canaliculi. The structural changes in the bile canaliculi detected in one patient may be evidence of a subclinical hepatic disease associated with PMR. The cholestatic hepatic dysfunction, common in PMR and manifested in over half of our patients by elevated serum AP levels, can easily be confirmed with special staining methods for visualizing the bile canaliculi in cytological liver specimens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1006209     DOI: 10.3109/03009747609099905

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  12 in total

1.  Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis.

Authors:  V Kyle; E P Wraight; B L Hazleman
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

2.  Association of autoimmune diseases with HLA-B8.

Authors:  J von Knorring
Journal:  Br Med J       Date:  1977-11-19

Review 3.  Clinical associations between arthritis and liver disease.

Authors:  P R Mills; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

4.  AIDS and dilated cardiomyopathy.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

5.  Polymyalgia rheumatica and antimitochondrial antibodies.

Authors:  M A Sattar; M I Cawley; T J Hamblin; J C Robertson
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

Review 6.  Liver involvement in giant cell arteritis.

Authors:  Y Ilan; E Ben-Chetrit
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

7.  Hepatocellular disease in the giant-cell arteritis/polymyalgia rheumatica syndrome.

Authors:  A S Leong; M H Alp
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

8.  Abnormal radionuclide liver scans in giant cell arteritis.

Authors:  J Jones; M V Kyle; B L Hazleman; P Wraight
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

Review 9.  [Clinical and serological findings of giant-cell arteritis].

Authors:  P Vaith; K Warnatz
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

Review 10.  Liver involvement in subjects with rheumatic disease.

Authors:  Carlo Selmi; Maria De Santis; M Eric Gershwin
Journal:  Arthritis Res Ther       Date:  2011-06-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.